High-frequency oscillatory ventilation versus synchronized intermittent mandatory ventilation plus pressure support in preterm infants with severe respiratory distress syndrome

Respiratory Care

Volumn 59, Issue 2, 2014, Pages 159-169

  Sun, Huiqing ^a,b   Cheng, Rui ^c   Kang, Wengqing ^a,b   Xiong, Hong ^a   Zhou, Chongchen ^b   Zhang, Yinghui ^b   Wang, Xiaoyang ^d,e   Zhu, Changlian ^a,f  

^a ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU CHILDREN S HOSPITAL   (China)

^c CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d Henan Key Laboratory for Neonatal Brain Injury   (China)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

High frequency oscillatory ventilation; Neurodevelopment; Preterm infants; Respiratory distress syndrome

Indexed keywords

IBUPROFEN; PORACTANT;

AIRWAY PRESSURE METER; BREATHING RATE; CLINICAL TRIAL; EDITORIAL; ENDOTRACHEAL INTUBATION; FEMALE; FOLLOW UP; HIGH FREQUENCY VENTILATION; HUMAN; INFANT; INTERMITTENT MANDATORY VENTILATION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NERVE CELL DIFFERENTIATION; NEWBORN INTENSIVE CARE; POSITIVE END EXPIRATORY PRESSURE VENTILATOR; PRESSURE SUPPORT VENTILATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; SURVIVAL RATE; TRACHEAL SUCTION CATHETER; TREATMENT OUTCOME;

HIGH-FREQUENCY OSCILLATORY VENTILATION; NEURODEVELOPMENT; PRETERM INFANTS; RESPIRATORY DISTRESS SYNDROME;

BRONCHOPULMONARY DYSPLASIA; FEMALE; GESTATIONAL AGE; HIGH-FREQUENCY VENTILATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INTERMITTENT POSITIVE-PRESSURE VENTILATION; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SAFETY; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 84893212816     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02382     Document Type: Editorial

References (38)

1. Huo K, Zhao Y, Feng H, Yao M, Savman K, Wang X, et al. Mortality rates of children aged under five in Henan province, China, 2004-2008. Paediatr Perinat Epidemiol 2010;24(4):343-348.
2. Kaplan HC, Lorch SA, Pinto-Martin J, Putt M, Silber JH. Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality. BMC Health Serv Res 2011;11:22.
3. Valcamonico A, Accorsi P, Sanzeni C, Martelli P, La Boria P, Cavazza A, et al. Mid-and long-term outcome of extremely low birth weight (ELBW) infants: an analysis of prognostic factors. J Matern Fetal Neonatal Med 2007;20(6):465-471.
4. Tissieres P, Myers P, Beghetti M, Berner M, and Rimensberger PC. Surfactant use based on the oxygenation response to lung recruitment during HFOV in VLBW infants. Intensive Care Med 2010; 36(7):1164-1170.
5. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants: 2010 update. Neonatology 2010;97(4):402-417.
6. Cools F, Askie LM, Offringa M, Asselin JM, Calvert SA, Courtney SE, et al. Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients' data. Lancet 2010;375(9731):2082-2091.
7. Verder H, Bohlin K, Kamper J, Lindwall R, Jonsson B. Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia. Acta Paediatr 2009;98(9): 1400-1408.
8. Kessel I, Waisman D, Barnet-Grinnes O, Ben Ari TZ, Rotschild A. Benefits of high frequency oscillatory ventilation for premature infants. Isr Med Assoc J 2010;12(3):144-149.
9. Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006;118(1):108-113.
10. Yoder BA, Siler-Khodr T, Winter VT, Coalson JJ. High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. Am J Respir Crit Care Med 2000;162(5):1867-1876.
11. Marlow N, Greenough A, Peacock JL, Marston L, Limb ES, Johnson AH, et al. Randomised trial of high frequency oscillatory ventilation or conventional ventilation in babies of gestational age 28 weeks or less: respiratory and neurological outcomes at 2 years. Arch Dis Child Fetal Neonatal Ed 2006;91(5):F320-326.
12. Truffert P, Paris-Llado J, Escande B, Magny JF, Cambonie G, Saliba E, et al. Neuromotor outcome at 2 years of very preterm infants who were treated with high-frequency oscillatory ventilation or conventional ventilation for neonatal respiratory distress syndrome. Pediatrics 2007;119(4):e860-865.
13. Plavka R, Kopecky P, Sebron V, Svihovec P, Zlatohlavkova B, Janus V. A prospective randomized comparison of conventional mechanical ventilation and very early high frequency oscillatory ventilation in extremely premature newborns with respiratory distress syndrome. Intensive Care Med 1999;25(1):68-75.
14. Courtney SE, Durand DJ, Asselin JM, Hudak ML, Aschner JL, Shoemaker CT. High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants. N Engl J Med 2002;347(9):643-652.
15. De Jaegere A, van Veenendaal MB, Michiels A, van Kaam AH. Lung recruitment using oxygenation during open lung high-frequency ventilation in preterm infants. Am J Respir Crit Care Med 2006; 174(6):639-645.
16. Moriette G, Paris-Llado J, Walti H, Escande B, Magny JF, Cambonie G, et al. Prospective randomized multicenter comparison of highfrequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with respiratory distress syndrome. Pediatrics 2001;107(2):363-372.
17. Baveja R, Christou H. Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006;30(4):209-218.
18. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116(6):1353-1360.
19. Cools F, Henderson-Smart DJ, Offringa M, Askie LM. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 2009(3):CD000104.
20. High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. The HIFI Study Group. N Engl J Med 1989;320(2): 88-93.
21. Johnson AH, Peacock JL, Greenough A, Marlow N, Limb ES, Marston L, et al. High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. N Engl J Med 2002; 347(9):633-642.
22. Krishnan RK, Meyers PA, Worwa C, Goertz R, Schauer G, Mammel MC. Standardized lung recruitment during high frequency and conventional ventilation: similar pathophysiologic and inflammatory responses in an animal model of respiratory distress syndrome. Intensive Care Med 2004;30(6):1195-1203.
23. Vento G, Matassa PG, Ameglio F, Capoluongo E, Zecca E, Tortorolo L, et al. HFOV in premature neonates: effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial. Intensive Care Med 2005;31(3):463-470.
24. Sherlock RL, Anderson PJ, Doyle LW. Neurodevelopmental sequelae of intraventricular haemorrhage at 8 years of age in a regional cohort of ELBW/very preterm infants. Early Hum Dev 2005;81(11): 909-916.
25. Larroque B, Ancel PY, Marret S, Marchand L, Andre M, Arnaud C, et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 2008;371(9615):813-820.
26. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009; 8(1):110-124.
27. Vidyasagar D, Velaphi S, Bhat VB. Surfactant replacement therapy in developing countries. Neonatology 2011;99(4):355-366.
28. Wang H, Gao X, Liu C, Yan C, Lin X, Yang C, et al. Morbidity and mortality of neonatal respiratory failure in china: surfactant treatment in very immature infants. Pediatrics 2012;129(3):e731-e740.
29. Halliday HL. Surfactants: past, present and future. J Perinatol 2008; 28(Suppl 1):S47-56.
30. van Kaam AH, De Jaegere AP, Borensztajn D, Rimensberger PC. Surfactant replacement therapy in preterm infants: a European survey. Neonatology 2011;100(1):71-77.
31. Ramanathan R, Sardesai S. Lung protective ventilatory strategies in very low birth weight infants. J Perinatol 2008;28(Suppl 1):S41-46.
32. Scopesi F, Calevo MG, Rolfe P, Arioni C, Traggiai C, Risso FM, et al. Volume targeted ventilation (volume guarantee) in the weaning phase of premature newborn infants. Pediatr Pulmonol 2007;42(10): 864-870.
33. Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010;362(21):1970-1979.
34. De Jaegere AP, van der Lee JH, Cante C, van Kaam AH. Early prediction of nasal continuous positive airway pressure failure in preterm infants less than 30 weeks gestation. Acta Paediatr 2012; 101(4):374-379.
35. Mahmoud RA, Roehr CC, Schmalisch G. Current methods of noninvasive ventilatory support for neonates. Paediatr Respir Rev 2011; 12(3):196-205.
36. Han W, Song J, Liu A, Huo K, Xu F, Cui S, et al. Trends in live births in the past 20 years in Zhengzhou, China Acta Obstet Gynecol Scand 2011;90(4):332-337.
37. Zhu WX, Lu L, Hesketh T. China's excess males, sex selective abortion, and one child policy: analysis of data from 2005 national intercensus survey. BMJ 2009;338:b1211.
38. Binet ME, Bujold E, Lefebvre F, Tremblay Y, Piedboeuf B. Role of Gender in Morbidity and Mortality of Extremely Premature Neonates. Am Perinatol 2012;29(3):159-166.